QIA Qiagen N.V.

Partial data

XETRA · DE · Healthcare · Diagnostics & Research · qiagen.com

38.83EUR+0.23%Mkt Cap: 8.69B $P/E: 22.7947d ago

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$40.66BUSDP/E 36.2

MTD

Mettler-Toledo International Inc.

$30.72BUSDP/E 34.6

Labcorp Holdings Inc.

$25.28BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.21BUSDP/E 24.2

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.83BUSDP/E 35.4

ERF

Eurofins Scientific SE

$14.16BUSDP/E 26.4

CRL

Charles River Laboratories International, Inc.

$14.56BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap8.69B USD

Enterprise Value9.37B USD

Revenue (TTM)2.28B USD

Gross Profit1.41B USD

Net Income (TTM)461.83M USD

Revenue/Share10.44 EUR

Last Price38.83 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees5.5K

CountryDE

SectorHealthcare

IndustryDiagnostics & Research

ISINNL0012169213

Valuation

P/E (Trailing)22.79

P/E (Forward)16.78

PEG1.09

EV/EBITDA11.74

EV/Revenue4.10

P/S3.69

P/B2.70

EPS (TTM)1.68

EPS (Forward)2.24

52W Range

36.3696% of range38.92

52W High38.92 EUR

52W Low36.36 EUR

Profitability

Gross Margin62.18%

Oper. Margin26.32%

EBITDA Margin34.96%

Profit Margin20.33%

ROE11.25%

ROA6.76%

Growth

Revenue Growth0.30%

Earnings Growth13.60%

Cash Flow & Leverage

Operating CF711.22M USD

CapEx (TTM)225.14M USD

FCF Margin17.75%

FCF Yield4.66%

Net Debt935.00M USD

Net Debt/EBITDA1.17

Balance Sheet

Debt/Equity0.48

Current Ratio2.85

Quick Ratio2.05

Book Value/Sh13.93 EUR

Cash/Share3.84 EUR

Dividends

Fwd Div Rate0.31 EUR

Trail. Div Rate0.36 EUR

Div. Yield0.79%

5Y Avg Yield—

Payout Ratio17.79%

Ex-Div DateJul 7, 2026

Pay Date—

Splits

Last Split19:20

Split DateJan 8, 2026

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)38.87 EUR

Upside (mean)+0.1%

Target Range32.00 EUR – 42.11 EUR

32.00+0.1% to mean42.11

# Analysts7

Ownership

Shares Out.206.50M

Float205.12M

Insiders0.48%

Institutions80.65%

Technical

SMA 5035.37 (+9.8%)

SMA 20037.10 (+4.6%)

Beta0.62

S&P 52W Chg18.16%

Avg Vol (30d)567.00K

Avg Vol (10d)600.52K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—